|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Abnet CC, Arnold M and Wei WQ:
Epidemiology of esophageal squamous cell carcinoma.
Gastroenterology. 154:360–373. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang H, Liu H, Chen Y, Zhu C, Fang W, Yu
Z, Mao W, Xiang J, Han Y, Chen Z, et al: Neoadjuvant
chemoradiotherapy followed by surgery versus surgery alone for
locally advanced squamous cell carcinoma of the esophagus
(NEOCRTEC5010): A phase III multicenter, randomized, open-label
clinical trial. J Clin Oncol. 36:2796–2803. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Herskovic A, Russell W, Liptay M, Fidler
MJ and Al-Sarraf M: Esophageal carcinoma advances in treatment
results for locally advanced disease: Review. Ann Oncol.
23:1095–1103. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Morris KV and Mattick JS: The rise of
regulatory RNA. Nat Rev Genet. 15:423–437. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Parasramka MA, Maji S, Matsuda A, Yan IK
and Patel T: Long non-coding RNAs as novel targets for therapy in
hepatocellular carcinoma. Pharmacol Ther. 161:67–78. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ulitsky I and Bartel DP: LincRNAs:
Genomics, evolution, and mechanisms. Cell. 154:26–46. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ma L, Bajic VB and Zhang Z: On the
classification of long non-coding RNAs. RNA Biol. 10:925–933. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rinn JL and Chang HY: Genome regulation by
long noncoding RNAs. Annu Rev Biochem. 81:145–166. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rinn JL, Kertesz M, Wang JK, Squazzo SL,
Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E and
Chang HY: Functional demarcation of active and silent chromatin
domains in human HOX loci by noncoding RNAs. Cell. 129:1311–1323.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Deng SJ, Chen HY, Ye Z, Deng SC, Zhu S,
Zeng Z, He C, Liu ML, Huang K, Zhong JX, et al: Hypoxia-induced
lncRNA-BX111 promotes metastasis and progression of pancreatic
cancer through regulating ZEB1 transcription. Oncogene.
37:5811–5828. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lin C, Zhang S, Wang Y, Wang Y, Nice E,
Guo C, Zhang E, Yu L, Li M, Liu C, et al: Functional role of a
novel long noncoding RNA TTN-AS1 in esophageal squamous cell
carcinoma progression and metastasis. Clin Cancer Res. 24:486–498.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pandey GK, Mitra S, Subhash S, Hertwig F,
Kanduri M, Mishra K, Fransson S, Ganeshram A, Mondal T, Bandaru S,
et al: The risk-associated long noncoding RNA NBAT-1 controls
neuroblastoma progression by regulating cell proliferation and
neuronal differentiation. Cancer Cell. 26:722–737. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Damas ND, Marcatti M, Come C, Christensen
LL, Nielsen MM, Baumgartner R, Gylling HM, Maglieri G, Rundsten CF,
Seemann SE, et al: SNHG5 promotes colorectal cancer cell survival
by counteracting STAU1-mediated mRNA destabilization. Nat Commun.
7:138752016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang K, Long B, Zhou LY, Liu F, Zhou QY,
Liu CY, Fan YY and Li PF: CARL lncRNA inhibits anoxia-induced
mitochondrial fission and apoptosis in cardiomyocytes by impairing
miR-539-dependent PHB2 downregulation. Nat Commun. 5:35962014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Peng WX, Koirala P and Mo YY:
lncRNA-mediated regulation of cell signaling in cancer. Oncogene.
36:5661–5667. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schmitt AM and Chang HY: Long noncoding
RNAs in cancer pathways. Cancer Cell. 29:452–463. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xiao G, Li Y, Wang Y, Zhao B, Zou Z, Hou
S, Jia X, Liu X, Yao Y, Wan J and Xiong H: lncRNA PRAL is closely
related to clinical prognosis of multiple myeloma and the
bortezomib sensitivity. Exp Cell Res. 370:254–263. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Qiu L, Tang Q, Li G and Chen K: Long
non-coding RNAs as biomarkers and therapeutic targets: Recent
insights into hepatocellular carcinoma. Life Sci. 191:273–282.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lin B, White JT, Ferguson C, Bumgarner R,
Friedman C, Trask B, Ellis W, Lange P, Hood L and Nelson PS:
PART-1: A novel human prostate-specific, androgen-regulated gene
that maps to chromosome 5q12. Cancer Res. 60:858–863.
2000.PubMed/NCBI
|
|
22
|
Lou T, Ke K, Zhang L, Miao C and Liu Y:
lncRNA PART1 facilitates the malignant progression of colorectal
cancer via miR-150-5p/LRG1 axis. J Cell Biochem. 121:4271–4281.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kang M, Ren M, Li Y, Fu Y, Deng M and Li
C: Exosome-mediated transfer of lncRNA PART1 induces gefitinib
resistance in esophageal squamous cell carcinoma via functioning as
a competing endogenous RNA. J Exp Clin Cancer Res. 37:1712018.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jin Z, Piao L, Sun G, Lv C, Jing Y and Jin
R: Long non-coding RNA PART1 exerts tumor suppressive functions in
glioma via sponging miR-190a-3p and inactivation of PTEN/AKT
pathway. Onco Targets Ther. 13:1073–1086. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xuan C, Jin M, Wang L, Xue S, An Q, Sun Q,
Wang L and Gao Y: PART1 and hsa-miR-429-Mediated SHCBP1 expression
is an independent predictor of poor prognosis in glioma patients.
Biomed Res Int. 2020:17670562020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kim JH, Hwang J, Jung JH, Lee HJ, Lee DY
and Kim SH: Molecular networks of FOXP family: Dual biologic
functions, interplay with other molecules and clinical implications
in cancer progression. Mol Cancer. 18:1802019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Herrero MJ and Gitton Y: The untold
stories of the speech gene, the FOXP2 cancer gene. Genes Cancer.
9:11–38. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gascoyne DM, Spearman H, Lyne L, Puliyadi
R, Perez-Alcantara M, Coulton L, Fisher SE, Croucher PI and Banham
AH: The forkhead transcription factor FOXP2 is required for
regulation of p21WAF1/CIP1 in 143B osteosarcoma cell growth arrest.
PLoS One. 10:e01285132015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen Z, Li J, Tian L, Zhou C, Gao Y, Zhou
F, Shi S, Feng X, Sun N, Yao R, et al: miRNA expression profile
reveals a prognostic signature for esophageal squamous cell
carcinoma. Cancer Lett. 350:34–42. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li JH, Liu S, Zhou H, Qu LH and Yang JH:
StarBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA
interaction networks from large-scale CLIP-Seq data. Nucleic Acids
Res. 42((Database Issue)): D92–D97. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tsai MC, Manor O, Wan Y, Mosammaparast N,
Wang JK, Lan F, Shi Y, Segal E and Chang HY: Long noncoding RNA as
modular scaffold of histone modification complexes. Science.
329:689–693. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hajjari M and Salavaty A: HOTAIR: An
oncogenic long non-coding RNA in different cancers. Cancer Biol
Med. 12:1–9. 2015.PubMed/NCBI
|
|
34
|
Zou ZW, Ma C, Medoro L, Chen L, Wang B,
Gupta R, Liu T, Yang XZ, Chen TT, Wang RZ, et al: lncRNA ANRIL is
up-regulated in nasopharyngeal carcinoma and promotes the cancer
progression via increasing proliferation, reprograming cell glucose
metabolism and inducing side-population stem-like cancer cells.
Oncotarget. 7:61741–61754. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hua L, Wang CY, Yao KH, Chen JT, Zhang JJ
and Ma WL: High expression of long non-coding RNA ANRIL is
associated with poor prognosis in hepatocellular carcinoma. Int J
Clin Exp Pathol. 8:3076–3082. 2015.PubMed/NCBI
|
|
36
|
Li M, Zhang W, Zhang S, Wang C and Lin Y:
PART1 expression is associated with poor prognosis and tumor
recurrence in stage I–III non-small cell lung cancer. J Cancer.
8:1795–1800. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sun M, Geng D, Li S, Chen Z and Zhao W:
lncRNA PART1 modulates toll-like receptor pathways to influence
cell proliferation and apoptosis in prostate cancer cells. Biol
Chem. 399:387–395. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hung T, Wang Y, Lin MF, Koegel AK, Kotake
Y, Grant GD, Horlings HM, Shah N, Umbricht C, Wang P, et al:
Extensive and coordinated transcription of noncoding RNAs within
cell-cycle promoters. Nat Genet. 43:621–629. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Huarte M, Guttman M, Feldser D, Garber M,
Koziol MJ, Kenzelmann-Broz D, Khalil AM, Zuk O, Amit I, Rabani M,
et al: A large intergenic noncoding RNA induced by p53 mediates
global gene repression in the p53 response. Cell. 142:409–419.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Guttman M, Amit I, Garber M, French C, Lin
MF, Feldser D, Huarte M, Zuk O, Carey BW, Cassady JP, et al:
Chromatin signature reveals over a thousand highly conserved large
non-coding RNAs in mammals. Nature. 458:223–227. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Xu TP, Wang YF, Xiong WL, Ma P, Wang WY,
Chen WM, Huang MD, Xia R, Wang R, Zhang EB, et al: E2F1 induces
TINCR transcriptional activity and accelerates gastric cancer
progression via activation of TINCR/STAU1/CDKN2B signaling axis.
Cell Death Dis. 8:e28372017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chen MT, Sun HF, Li LD, Zhao Y, Yang LP,
Gao SP and Jin W: Downregulation of FOXP2 promotes breast cancer
migration and invasion through TGFβ/SMAD signaling pathway. Oncol
Lett. 15:8582–8588. 2018.PubMed/NCBI
|
|
43
|
Wu J, Liu P, Tang H, Shuang Z, Qiu Q,
Zhang L, Song C, Liu L, Xie X and Xiao X: FOXP2 promotes tumor
proliferation and metastasis by Targeting GRP78 in triple-negative
breast cancer. Curr Cancer Drug Targets. 18:382–389. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wapinski O and Chang HY: Long noncoding
RNAs and human disease. Trends Cell Biol. 21:354–361. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wang H, Wei X, Wu B, Su J, Tan W and Yang
K: Tumor-educated platelet miR-34c-3p and miR-18a-5p as potential
liquid biopsy biomarkers for nasopharyngeal carcinoma diagnosis.
Cancer Manag Res. 11:3351–3360. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Li Y, He ZC, Liu Q, Zhou K, Shi Y, Yao XH,
Zhang X, Kung HF, Ping YF and Bian XW: Large intergenic non-coding
RNA-RoR inhibits aerobic glycolysis of glioblastoma cells via Akt
pathway. J Cancer. 9:880–889. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Liang C, Zhang X, Wang HM, Liu XM, Zhang
XJ, Zheng B, Qian GR and Ma ZL: MicroRNA-18a-5p functions as an
oncogene by directly targeting IRF2 in lung cancer. Cell Death Dis.
8:e27642017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Qin YR, Tang H, Xie F, Liu H, Zhu Y, Ai J,
Chen L, Li Y, Kwong DL, Fu L and Guan XY: Characterization of
tumor-suppressive function of SOX6 in human esophageal squamous
cell carcinoma. Clin Cancer Res. 17:46–55. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Wang J, Ding S, Duan Z, Xie Q, Zhang T,
Zhang X, Wang Y, Chen X, Zhuang H and Lu F: Role of p14ARF-HDM2-p53
axis in SOX6-mediated tumor suppression. Oncogene. 35:1692–1702.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Jiang W, Yuan Q, Jiang Y, Huang L, Chen C,
Hu G, Wan R, Wang X and Yang L: Identification of Sox6 as a
regulator of pancreatic cancer development. J Cell Mol Med.
22:1864–1872. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Iguchi H, Urashima Y, Inagaki Y, Ikeda Y,
Okamura M, Tanaka T, Uchida A, Yamamoto TT, Kodama T and Sakai J:
SOX6 suppresses cyclin D1 promoter activity by interacting with
beta-catenin and histone deacetylase 1, and its down-regulation
induces pancreatic beta-cell proliferation. J Biol Chem.
282:19052–19061. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Kim J, Woo AJ, Chu J, Snow JW, Fujiwara Y,
Kim CG, Cantor AB and Orkin SH: A Myc network accounts for
similarities between embryonic stem and cancer cell transcription
programs. Cell. 143:313–324. 2010. View Article : Google Scholar : PubMed/NCBI
|
